This report aims to provide a comprehensive presentation of the global market for Respiratory Disorders Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Disorders Drug. This report contains market size and forecasts of Respiratory Disorders Drug in global, including the following market information:
Global Respiratory Disorders Drug Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Respiratory Disorders Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Capsule Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Respiratory Disorders Drug include AstraZeneca, MSD, Boehringer Ingelheim, Biogen, Pfizer, Teva, Novartis, Johnson & Johnson and Eli Lilly, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Respiratory Disorders Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Respiratory Disorders Drug Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Respiratory Disorders Drug Market Segment Percentages, by Type, 2022 (%)
Capsule
Suspension Agent
Injection
Gas (Powder) Mist
Tablets
Solution
Granules
Dropping Pill
Patch
Other
Global Respiratory Disorders Drug Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Respiratory Disorders Drug Market Segment Percentages, by Application, 2022 (%)
Clearing Away Heat And Detoxifying Drugs
Expectorant
Cold Medicine
Antiasthmatic
COPD Treatment Medicine
Cough Medicine
Respiratory Stimulant
Other
Global Respiratory Disorders Drug Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Respiratory Disorders Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Respiratory Disorders Drug revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Respiratory Disorders Drug revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
MSD
Boehringer Ingelheim
Biogen
Pfizer
Teva
Novartis
Johnson & Johnson
Eli Lilly
Otsuka
Merck
Takeda
FibroGen
Amgen
Dr. Reddy's Laboratories
Dainippon Sumitomo
Abbott
Horizon Pharma
Zambon
Moehs
Pharmazell
Nippon Rika
Chengyi Pharma
Wuhan Grand Hoyo
Manus Aktteva Biopharma
Beijing Jiuhe Pharmaceutical
Daiichi Sankyo Pharmaceutical
Sinopharm
CTTQ
Yangtze River Pharmaceutical Group
Outline of Major Chapters:
Chapter 1: Introduces the definition of Respiratory Disorders Drug, market overview.
Chapter 2: Global Respiratory Disorders Drug market size in revenue.
Chapter 3: Detailed analysis of Respiratory Disorders Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Respiratory Disorders Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Respiratory Disorders Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Respiratory Disorders Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Respiratory Disorders Drug Overall Market Size
2.1 Global Respiratory Disorders Drug Market Size: 2022 VS 2030
2.2 Global Respiratory Disorders Drug Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Respiratory Disorders Drug Players in Global Market
3.2 Top Global Respiratory Disorders Drug Companies Ranked by Revenue
3.3 Global Respiratory Disorders Drug Revenue by Companies
3.4 Top 3 and Top 5 Respiratory Disorders Drug Companies in Global Market, by Revenue in 2022
3.5 Global Companies Respiratory Disorders Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Respiratory Disorders Drug Players in Global Market
3.6.1 List of Global Tier 1 Respiratory Disorders Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Respiratory Disorders Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Respiratory Disorders Drug Market Size Markets, 2022 & 2030
4.1.2 Capsule
4.1.3 Suspension Agent
4.1.4 Injection
4.1.5 Gas (Powder) Mist
4.1.6 Tablets
4.1.7 Solution
4.1.8 Granules
4.1.9 Dropping Pill
4.1.10 Patch
4.1.11 Other
4.2 By Type - Global Respiratory Disorders Drug Revenue & Forecasts
4.2.1 By Type - Global Respiratory Disorders Drug Revenue, 2018-2023
4.2.2 By Type - Global Respiratory Disorders Drug Revenue, 2024-2030
4.2.3 By Type - Global Respiratory Disorders Drug Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Respiratory Disorders Drug Market Size, 2022 & 2030
5.1.2 Clearing Away Heat And Detoxifying Drugs
5.1.3 Expectorant
5.1.4 Cold Medicine
5.1.5 Antiasthmatic
5.1.6 COPD Treatment Medicine
5.1.7 Cough Medicine
5.1.8 Respiratory Stimulant
5.1.9 Other
5.2 By Application - Global Respiratory Disorders Drug Revenue & Forecasts
5.2.1 By Application - Global Respiratory Disorders Drug Revenue, 2018-2023
5.2.2 By Application - Global Respiratory Disorders Drug Revenue, 2024-2030
5.2.3 By Application - Global Respiratory Disorders Drug Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Respiratory Disorders Drug Market Size, 2022 & 2030
6.2 By Region - Global Respiratory Disorders Drug Revenue & Forecasts
6.2.1 By Region - Global Respiratory Disorders Drug Revenue, 2018-2023
6.2.2 By Region - Global Respiratory Disorders Drug Revenue, 2024-2030
6.2.3 By Region - Global Respiratory Disorders Drug Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Respiratory Disorders Drug Revenue, 2018-2030
6.3.2 US Respiratory Disorders Drug Market Size, 2018-2030
6.3.3 Canada Respiratory Disorders Drug Market Size, 2018-2030
6.3.4 Mexico Respiratory Disorders Drug Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Respiratory Disorders Drug Revenue, 2018-2030
6.4.2 Germany Respiratory Disorders Drug Market Size, 2018-2030
6.4.3 France Respiratory Disorders Drug Market Size, 2018-2030
6.4.4 U.K. Respiratory Disorders Drug Market Size, 2018-2030
6.4.5 Italy Respiratory Disorders Drug Market Size, 2018-2030
6.4.6 Russia Respiratory Disorders Drug Market Size, 2018-2030
6.4.7 Nordic Countries Respiratory Disorders Drug Market Size, 2018-2030
6.4.8 Benelux Respiratory Disorders Drug Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Respiratory Disorders Drug Revenue, 2018-2030
6.5.2 China Respiratory Disorders Drug Market Size, 2018-2030
6.5.3 Japan Respiratory Disorders Drug Market Size, 2018-2030
6.5.4 South Korea Respiratory Disorders Drug Market Size, 2018-2030
6.5.5 Southeast Asia Respiratory Disorders Drug Market Size, 2018-2030
6.5.6 India Respiratory Disorders Drug Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Respiratory Disorders Drug Revenue, 2018-2030
6.6.2 Brazil Respiratory Disorders Drug Market Size, 2018-2030
6.6.3 Argentina Respiratory Disorders Drug Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Respiratory Disorders Drug Revenue, 2018-2030
6.7.2 Turkey Respiratory Disorders Drug Market Size, 2018-2030
6.7.3 Israel Respiratory Disorders Drug Market Size, 2018-2030
6.7.4 Saudi Arabia Respiratory Disorders Drug Market Size, 2018-2030
6.7.5 UAE Respiratory Disorders Drug Market Size, 2018-2030
7 Respiratory Disorders Drug Companies Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Company Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Respiratory Disorders Drug Major Product Offerings
7.1.4 AstraZeneca Respiratory Disorders Drug Revenue in Global Market (2018-2023)
7.1.5 AstraZeneca Key News & Latest Developments
7.2 MSD
7.2.1 MSD Company Summary
7.2.2 MSD Business Overview
7.2.3 MSD Respiratory Disorders Drug Major Product Offerings
7.2.4 MSD Respiratory Disorders Drug Revenue in Global Market (2018-2023)
7.2.5 MSD Key News & Latest Developments
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Company Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Respiratory Disorders Drug Major Product Offerings
7.3.4 Boehringer Ingelheim Respiratory Disorders Drug Revenue in Global Market (2018-2023)
7.3.5 Boehringer Ingelheim Key News & Latest Developments
7.4 Biogen
7.4.1 Biogen Company Summary
7.4.2 Biogen Business Overview
7.4.3 Biogen Respiratory Disorders Drug Major Product Offerings
7.4.4 Biogen Respiratory Disorders Drug Revenue in Global Market (2018-2023)
7.4.5 Biogen Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Respiratory Disorders Drug Major Product Offerings
7.5.4 Pfizer Respiratory Disorders Drug Revenue in Global Market (2018-2023)
7.5.5 Pfizer Key News & Latest Developments
7.6 Teva
7.6.1 Teva Company Summary
7.6.2 Teva Business Overview
7.6.3 Teva Respiratory Disorders Drug Major Product Offerings
7.6.4 Teva Respiratory Disorders Drug Revenue in Global Market (2018-2023)
7.6.5 Teva Key News & Latest Developments
7.7 Novartis
7.7.1 Novartis Company Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Respiratory Disorders Drug Major Product Offerings
7.7.4 Novartis Respiratory Disorders Drug Revenue in Global Market (2018-2023)
7.7.5 Novartis Key News & Latest Developments
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Company Summary
7.8.2 Johnson & Johnson Business Overview
7.8.3 Johnson & Johnson Respiratory Disorders Drug Major Product Offerings
7.8.4 Johnson & Johnson Respiratory Disorders Drug Revenue in Global Market (2018-2023)
7.8.5 Johnson & Johnson Key News & Latest Developments
7.9 Eli Lilly
7.9.1 Eli Lilly Company Summary
7.9.2 Eli Lilly Business Overview
7.9.3 Eli Lilly Respiratory Disorders Drug Major Product Offerings
7.9.4 Eli Lilly Respiratory Disorders Drug Revenue in Global Market (2018-2023)
7.9.5 Eli Lilly Key News & Latest Developments
7.10 Otsuka
7.10.1 Otsuka Company Summary
7.10.2 Otsuka Business Overview
7.10.3 Otsuka Respiratory Disorders Drug Major Product Offerings
7.10.4 Otsuka Respiratory Disorders Drug Revenue in Global Market (2018-2023)
7.10.5 Otsuka Key News & Latest Developments
7.11 Merck
7.11.1 Merck Company Summary
7.11.2 Merck Business Overview
7.11.3 Merck Respiratory Disorders Drug Major Product Offerings
7.11.4 Merck Respiratory Disorders Drug Revenue in Global Market (2018-2023)
7.11.5 Merck Key News & Latest Developments
7.12 Takeda
7.12.1 Takeda Company Summary
7.12.2 Takeda Business Overview
7.12.3 Takeda Respiratory Disorders Drug Major Product Offerings
7.12.4 Takeda Respiratory Disorders Drug Revenue in Global Market (2018-2023)
7.12.5 Takeda Key News & Latest Developments
7.13 FibroGen
7.13.1 FibroGen Company Summary
7.13.2 FibroGen Business Overview
7.13.3 FibroGen Respiratory Disorders Drug Major Product Offerings
7.13.4 FibroGen Respiratory Disorders Drug Revenue in Global Market (2018-2023)
7.13.5 FibroGen Key News & Latest Developments
7.14 Amgen
7.14.1 Amgen Company Summary
7.14.2 Amgen Business Overview
7.14.3 Amgen Respiratory Disorders Drug Major Product Offerings
7.14.4 Amgen Respiratory Disorders Drug Revenue in Global Market (2018-2023)
7.14.5 Amgen Key News & Latest Developments
7.15 Dr. Reddy's Laboratories
7.15.1 Dr. Reddy's Laboratories Company Summary
7.15.2 Dr. Reddy's Laboratories Business Overview
7.15.3 Dr. Reddy's Laboratories Respiratory Disorders Drug Major Product Offerings
7.15.4 Dr. Reddy's Laboratories Respiratory Disorders Drug Revenue in Global Market (2018-2023)
7.15.5 Dr. Reddy's Laboratories Key News & Latest Developments
7.16 Dainippon Sumitomo
7.16.1 Dainippon Sumitomo Company Summary
7.16.2 Dainippon Sumitomo Business Overview
7.16.3 Dainippon Sumitomo Respiratory Disorders Drug Major Product Offerings
7.16.4 Dainippon Sumitomo Respiratory Disorders Drug Revenue in Global Market (2018-2023)
7.16.5 Dainippon Sumitomo Key News & Latest Developments
7.17 Abbott
7.17.1 Abbott Company Summary
7.17.2 Abbott Business Overview
7.17.3 Abbott Respiratory Disorders Drug Major Product Offerings
7.17.4 Abbott Respiratory Disorders Drug Revenue in Global Market (2018-2023)
7.17.5 Abbott Key News & Latest Developments
7.18 Horizon Pharma
7.18.1 Horizon Pharma Company Summary
7.18.2 Horizon Pharma Business Overview
7.18.3 Horizon Pharma Respiratory Disorders Drug Major Product Offerings
7.18.4 Horizon Pharma Respiratory Disorders Drug Revenue in Global Market (2018-2023)
7.18.5 Horizon Pharma Key News & Latest Developments
7.19 Zambon
7.19.1 Zambon Company Summary
7.19.2 Zambon Business Overview
7.19.3 Zambon Respiratory Disorders Drug Major Product Offerings
7.19.4 Zambon Respiratory Disorders Drug Revenue in Global Market (2018-2023)
7.19.5 Zambon Key News & Latest Developments
7.20 Moehs
7.20.1 Moehs Company Summary
7.20.2 Moehs Business Overview
7.20.3 Moehs Respiratory Disorders Drug Major Product Offerings
7.20.4 Moehs Respiratory Disorders Drug Revenue in Global Market (2018-2023)
7.20.5 Moehs Key News & Latest Developments
7.21 Pharmazell
7.21.1 Pharmazell Company Summary
7.21.2 Pharmazell Business Overview
7.21.3 Pharmazell Respiratory Disorders Drug Major Product Offerings
7.21.4 Pharmazell Respiratory Disorders Drug Revenue in Global Market (2018-2023)
7.21.5 Pharmazell Key News & Latest Developments
7.22 Nippon Rika
7.22.1 Nippon Rika Company Summary
7.22.2 Nippon Rika Business Overview
7.22.3 Nippon Rika Respiratory Disorders Drug Major Product Offerings
7.22.4 Nippon Rika Respiratory Disorders Drug Revenue in Global Market (2018-2023)
7.22.5 Nippon Rika Key News & Latest Developments
7.23 Chengyi Pharma
7.23.1 Chengyi Pharma Company Summary
7.23.2 Chengyi Pharma Business Overview
7.23.3 Chengyi Pharma Respiratory Disorders Drug Major Product Offerings
7.23.4 Chengyi Pharma Respiratory Disorders Drug Revenue in Global Market (2018-2023)
7.23.5 Chengyi Pharma Key News & Latest Developments
7.24 Wuhan Grand Hoyo
7.24.1 Wuhan Grand Hoyo Company Summary
7.24.2 Wuhan Grand Hoyo Business Overview
7.24.3 Wuhan Grand Hoyo Respiratory Disorders Drug Major Product Offerings
7.24.4 Wuhan Grand Hoyo Respiratory Disorders Drug Revenue in Global Market (2018-2023)
7.24.5 Wuhan Grand Hoyo Key News & Latest Developments
7.25 Manus Aktteva Biopharma
7.25.1 Manus Aktteva Biopharma Company Summary
7.25.2 Manus Aktteva Biopharma Business Overview
7.25.3 Manus Aktteva Biopharma Respiratory Disorders Drug Major Product Offerings
7.25.4 Manus Aktteva Biopharma Respiratory Disorders Drug Revenue in Global Market (2018-2023)
7.25.5 Manus Aktteva Biopharma Key News & Latest Developments
7.26 Beijing Jiuhe Pharmaceutical
7.26.1 Beijing Jiuhe Pharmaceutical Company Summary
7.26.2 Beijing Jiuhe Pharmaceutical Business Overview
7.26.3 Beijing Jiuhe Pharmaceutical Respiratory Disorders Drug Major Product Offerings
7.26.4 Beijing Jiuhe Pharmaceutical Respiratory Disorders Drug Revenue in Global Market (2018-2023)
7.26.5 Beijing Jiuhe Pharmaceutical Key News & Latest Developments
7.27 Daiichi Sankyo Pharmaceutical
7.27.1 Daiichi Sankyo Pharmaceutical Company Summary
7.27.2 Daiichi Sankyo Pharmaceutical Business Overview
7.27.3 Daiichi Sankyo Pharmaceutical Respiratory Disorders Drug Major Product Offerings
7.27.4 Daiichi Sankyo Pharmaceutical Respiratory Disorders Drug Revenue in Global Market (2018-2023)
7.27.5 Daiichi Sankyo Pharmaceutical Key News & Latest Developments
7.28 Sinopharm
7.28.1 Sinopharm Company Summary
7.28.2 Sinopharm Business Overview
7.28.3 Sinopharm Respiratory Disorders Drug Major Product Offerings
7.28.4 Sinopharm Respiratory Disorders Drug Revenue in Global Market (2018-2023)
7.28.5 Sinopharm Key News & Latest Developments
7.29 CTTQ
7.29.1 CTTQ Company Summary
7.29.2 CTTQ Business Overview
7.29.3 CTTQ Respiratory Disorders Drug Major Product Offerings
7.29.4 CTTQ Respiratory Disorders Drug Revenue in Global Market (2018-2023)
7.29.5 CTTQ Key News & Latest Developments
7.30 Yangtze River Pharmaceutical Group
7.30.1 Yangtze River Pharmaceutical Group Company Summary
7.30.2 Yangtze River Pharmaceutical Group Business Overview
7.30.3 Yangtze River Pharmaceutical Group Respiratory Disorders Drug Major Product Offerings
7.30.4 Yangtze River Pharmaceutical Group Respiratory Disorders Drug Revenue in Global Market (2018-2023)
7.30.5 Yangtze River Pharmaceutical Group Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Respiratory Disorders Drug Market Opportunities & Trends in Global Market
Table 2. Respiratory Disorders Drug Market Drivers in Global Market
Table 3. Respiratory Disorders Drug Market Restraints in Global Market
Table 4. Key Players of Respiratory Disorders Drug in Global Market
Table 5. Top Respiratory Disorders Drug Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Respiratory Disorders Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Respiratory Disorders Drug Revenue Share by Companies, 2018-2023
Table 8. Global Companies Respiratory Disorders Drug Product Type
Table 9. List of Global Tier 1 Respiratory Disorders Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Respiratory Disorders Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Respiratory Disorders Drug Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Respiratory Disorders Drug Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Respiratory Disorders Drug Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Respiratory Disorders Drug Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Respiratory Disorders Drug Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Respiratory Disorders Drug Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Respiratory Disorders Drug Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Respiratory Disorders Drug Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Respiratory Disorders Drug Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Respiratory Disorders Drug Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Respiratory Disorders Drug Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Respiratory Disorders Drug Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Respiratory Disorders Drug Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Respiratory Disorders Drug Revenue, (US$, Mn), 2024-2030
Table 30. AstraZeneca Company Summary
Table 31. AstraZeneca Respiratory Disorders Drug Product Offerings
Table 32. AstraZeneca Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 33. AstraZeneca Key News & Latest Developments
Table 34. MSD Company Summary
Table 35. MSD Respiratory Disorders Drug Product Offerings
Table 36. MSD Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 37. MSD Key News & Latest Developments
Table 38. Boehringer Ingelheim Company Summary
Table 39. Boehringer Ingelheim Respiratory Disorders Drug Product Offerings
Table 40. Boehringer Ingelheim Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 41. Boehringer Ingelheim Key News & Latest Developments
Table 42. Biogen Company Summary
Table 43. Biogen Respiratory Disorders Drug Product Offerings
Table 44. Biogen Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 45. Biogen Key News & Latest Developments
Table 46. Pfizer Company Summary
Table 47. Pfizer Respiratory Disorders Drug Product Offerings
Table 48. Pfizer Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Teva Company Summary
Table 51. Teva Respiratory Disorders Drug Product Offerings
Table 52. Teva Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 53. Teva Key News & Latest Developments
Table 54. Novartis Company Summary
Table 55. Novartis Respiratory Disorders Drug Product Offerings
Table 56. Novartis Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 57. Novartis Key News & Latest Developments
Table 58. Johnson & Johnson Company Summary
Table 59. Johnson & Johnson Respiratory Disorders Drug Product Offerings
Table 60. Johnson & Johnson Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 61. Johnson & Johnson Key News & Latest Developments
Table 62. Eli Lilly Company Summary
Table 63. Eli Lilly Respiratory Disorders Drug Product Offerings
Table 64. Eli Lilly Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 65. Eli Lilly Key News & Latest Developments
Table 66. Otsuka Company Summary
Table 67. Otsuka Respiratory Disorders Drug Product Offerings
Table 68. Otsuka Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 69. Otsuka Key News & Latest Developments
Table 70. Merck Company Summary
Table 71. Merck Respiratory Disorders Drug Product Offerings
Table 72. Merck Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 73. Merck Key News & Latest Developments
Table 74. Takeda Company Summary
Table 75. Takeda Respiratory Disorders Drug Product Offerings
Table 76. Takeda Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 77. Takeda Key News & Latest Developments
Table 78. FibroGen Company Summary
Table 79. FibroGen Respiratory Disorders Drug Product Offerings
Table 80. FibroGen Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 81. FibroGen Key News & Latest Developments
Table 82. Amgen Company Summary
Table 83. Amgen Respiratory Disorders Drug Product Offerings
Table 84. Amgen Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 85. Amgen Key News & Latest Developments
Table 86. Dr. Reddy's Laboratories Company Summary
Table 87. Dr. Reddy's Laboratories Respiratory Disorders Drug Product Offerings
Table 88. Dr. Reddy's Laboratories Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 89. Dr. Reddy's Laboratories Key News & Latest Developments
Table 90. Dainippon Sumitomo Company Summary
Table 91. Dainippon Sumitomo Respiratory Disorders Drug Product Offerings
Table 92. Dainippon Sumitomo Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 93. Dainippon Sumitomo Key News & Latest Developments
Table 94. Abbott Company Summary
Table 95. Abbott Respiratory Disorders Drug Product Offerings
Table 96. Abbott Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 97. Abbott Key News & Latest Developments
Table 98. Horizon Pharma Company Summary
Table 99. Horizon Pharma Respiratory Disorders Drug Product Offerings
Table 100. Horizon Pharma Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 101. Horizon Pharma Key News & Latest Developments
Table 102. Zambon Company Summary
Table 103. Zambon Respiratory Disorders Drug Product Offerings
Table 104. Zambon Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 105. Zambon Key News & Latest Developments
Table 106. Moehs Company Summary
Table 107. Moehs Respiratory Disorders Drug Product Offerings
Table 108. Moehs Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 109. Moehs Key News & Latest Developments
Table 110. Pharmazell Company Summary
Table 111. Pharmazell Respiratory Disorders Drug Product Offerings
Table 112. Pharmazell Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 113. Pharmazell Key News & Latest Developments
Table 114. Nippon Rika Company Summary
Table 115. Nippon Rika Respiratory Disorders Drug Product Offerings
Table 116. Nippon Rika Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 117. Nippon Rika Key News & Latest Developments
Table 118. Chengyi Pharma Company Summary
Table 119. Chengyi Pharma Respiratory Disorders Drug Product Offerings
Table 120. Chengyi Pharma Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 121. Chengyi Pharma Key News & Latest Developments
Table 122. Wuhan Grand Hoyo Company Summary
Table 123. Wuhan Grand Hoyo Respiratory Disorders Drug Product Offerings
Table 124. Wuhan Grand Hoyo Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 125. Wuhan Grand Hoyo Key News & Latest Developments
Table 126. Manus Aktteva Biopharma Company Summary
Table 127. Manus Aktteva Biopharma Respiratory Disorders Drug Product Offerings
Table 128. Manus Aktteva Biopharma Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 129. Manus Aktteva Biopharma Key News & Latest Developments
Table 130. Beijing Jiuhe Pharmaceutical Company Summary
Table 131. Beijing Jiuhe Pharmaceutical Respiratory Disorders Drug Product Offerings
Table 132. Beijing Jiuhe Pharmaceutical Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 133. Beijing Jiuhe Pharmaceutical Key News & Latest Developments
Table 134. Daiichi Sankyo Pharmaceutical Company Summary
Table 135. Daiichi Sankyo Pharmaceutical Respiratory Disorders Drug Product Offerings
Table 136. Daiichi Sankyo Pharmaceutical Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 137. Daiichi Sankyo Pharmaceutical Key News & Latest Developments
Table 138. Sinopharm Company Summary
Table 139. Sinopharm Respiratory Disorders Drug Product Offerings
Table 140. Sinopharm Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 141. Sinopharm Key News & Latest Developments
Table 142. CTTQ Company Summary
Table 143. CTTQ Respiratory Disorders Drug Product Offerings
Table 144. CTTQ Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 145. CTTQ Key News & Latest Developments
Table 146. Yangtze River Pharmaceutical Group Company Summary
Table 147. Yangtze River Pharmaceutical Group Respiratory Disorders Drug Product Offerings
Table 148. Yangtze River Pharmaceutical Group Respiratory Disorders Drug Revenue (US$, Mn) & (2018-2023)
Table 149. Yangtze River Pharmaceutical Group Key News & Latest Developments
List of Figures
Figure 1. Respiratory Disorders Drug Segment by Type in 2022
Figure 2. Respiratory Disorders Drug Segment by Application in 2022
Figure 3. Global Respiratory Disorders Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Respiratory Disorders Drug Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Respiratory Disorders Drug Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Respiratory Disorders Drug Revenue in 2022
Figure 8. By Type - Global Respiratory Disorders Drug Revenue Market Share, 2018-2030
Figure 9. By Application - Global Respiratory Disorders Drug Revenue Market Share, 2018-2030
Figure 10. By Type - Global Respiratory Disorders Drug Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Respiratory Disorders Drug Revenue Market Share, 2018-2030
Figure 12. By Application - Global Respiratory Disorders Drug Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Respiratory Disorders Drug Revenue Market Share, 2018-2030
Figure 14. By Region - Global Respiratory Disorders Drug Revenue Market Share, 2018-2030
Figure 15. By Country - North America Respiratory Disorders Drug Revenue Market Share, 2018-2030
Figure 16. US Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Respiratory Disorders Drug Revenue Market Share, 2018-2030
Figure 20. Germany Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 21. France Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Respiratory Disorders Drug Revenue Market Share, 2018-2030
Figure 28. China Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 32. India Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Respiratory Disorders Drug Revenue Market Share, 2018-2030
Figure 34. Brazil Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Respiratory Disorders Drug Revenue Market Share, 2018-2030
Figure 37. Turkey Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Respiratory Disorders Drug Revenue, (US$, Mn), 2018-2030
Figure 41. AstraZeneca Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. MSD Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Boehringer Ingelheim Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Biogen Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Pfizer Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Teva Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Novartis Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Johnson & Johnson Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Eli Lilly Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Otsuka Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Merck Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Takeda Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. FibroGen Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Amgen Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Dr. Reddy's Laboratories Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Dainippon Sumitomo Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Abbott Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Horizon Pharma Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Zambon Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Moehs Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. Pharmazell Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 62. Nippon Rika Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 63. Chengyi Pharma Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 64. Wuhan Grand Hoyo Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 65. Manus Aktteva Biopharma Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 66. Beijing Jiuhe Pharmaceutical Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 67. Daiichi Sankyo Pharmaceutical Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 68. Sinopharm Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 69. CTTQ Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 70. Yangtze River Pharmaceutical Group Respiratory Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
